Buggio, Laura

No ORCID on file · 6 papers in corpus · active 2018

Study types

  • article 4
  • other 2

Condition tags

  • endometriosis 6
other 2018
·doi:10.25384/sage.c.4070606.v1

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

other 2018
·doi:10.25384/sage.c.4070606

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

article 2018
·doi:10.25384/sage.6144434

Supplemental Material, Supplemental_Table_1 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
·doi:10.25384/sage.6144434.v1

Supplemental Material, Supplemental_Table_1 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
·doi:10.25384/sage.6144437

Supplemental Material, Supplemental_Table_2 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…

article 2018
·doi:10.25384/sage.6144437.v1

Supplemental Material, Supplemental_Table_2 for Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain? by Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio…